Skip to content

Toggle navigation

News
- Press Releases
- In the News
Contact

About
Tailwind
Pipeline & Programs
Join us
- Leading Together
- Find your Position

About
Tailwind
Pipeline & Programs
Join us
- Leading Together
- Find your Position
News
- Press Releases
Contact
Terms of Use
Privacy Policy

Press Releases

Back to Press Releases

Startup to use ‘natural killer’ cells on cancer: Catamaran Bio debuts with $42 million from VC investors

Privacy Policy
Terms of Use
Contact
Site Credits
LinkedIn

©2024 Catamaran Bio, Inc. All Rights Reserved.

TAILWIND is a registered trademark of Catamaran Bio. Catamaran is a trademark of Catamaran Bio. All other trademarks referenced herein are the property of their respective owners.

©2024 Catamaran Bio, Inc. All Rights Reserved.

TAILWIND is a registered trademark of Catamaran Bio. Catamaran is a trademark of Catamaran Bio. All other trademarks referenced herein are the property of their respective owners.